Sana Biotechnology Inc
Ownership
Ownership Structure
Who owns Sana Biotechnology Inc (SANA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 63.8% of the shares are freely tradable; institutional investors hold 82.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| FMR Inc | 12.50 | 37,430,284 | +0.0 | 03/31/2026 |
| Flagship Ventures Management, Inc. | 8.35 | 25,001,856 | +0.0 | 06/30/2026 |
| BlackRock Inc | 4.76 | 14,240,175 | +0.1 | 03/31/2026 |
| State Street Corp | 3.52 | 10,538,086 | +30.8 | 03/31/2026 |
| Canada Pension Plan Investment Board | 3.41 | 10,218,400 | +0.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 2.48 | 7,434,724 | +0.0 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 5.05 | 15,131,616 | +0.0 | 07/31/2026 |
| Fidelity Growth Company Fund | 3.51 | 10,495,617 | +0.0 | 07/31/2026 |
| State Street® SPDR® S&P® Biotech ETF | 2.50 | 7,468,981 | -1.1 | 08/31/2026 |
| Vanguard MStar Total Stk Mkt Idx Invest | 2.09 | 6,251,644 | +0.0 | 07/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Patel Dhavalkumar Dhirajlal | EVP, Chief Scientific Officer | 183,352 | 568,391 $ | Aug 27, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | Patel Dhavalkumar Dhirajlal | EVP, Chief Scientific Officer | Other | 41,158 | 4.11 | 169,159 |
| Aug 26, 2026 | Patel Dhavalkumar Dhirajlal | EVP, Chief Scientific Officer | Other | 125,000 | 0.00 | – |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.